FK-506: Profile of an important new immunosuppressant
Data up to Jan 2025
Total Citations Per Year
Abstract
References (62)
A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase
1989 • 1,376 citations
FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.
1987 • 1,216 citations
FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.
1987 • 1,209 citations
FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATION
1989 • 1,043 citations
A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin
1989 • 1,010 citations
The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.
1989 • 667 citations
Medicine and the Law
1987 • 541 citations
Inhibition of the immune response by rapamycin, a new antifungal antibiotic
1977 • 444 citations
Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation.
1987 • 416 citations
South Africa
1985 • 333 citations
FK-506 — How much potential?
1989 • 181 citations
STUDIES OF THE INDUCTION AND MAINTENANCE OF LONG-TERM GRAFT ACCEPTANCE BY TREATMENT WITH FK506 IN HETEROTOPIC CARDIAC ALLOTRANSPLANTATION IN RATS
1987 • 169 citations
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction.
1988 • 160 citations
A highly sensitive method to assay FK-506 levels in plasma.
1987 • 149 citations
STUDIES OF THE EFFECTS OF FK506 ON RENAL ALLOGRAFTING IN THE BEAGLE DOG
1987 • 137 citations
FK-506, a potent novel immunosuppressive agent, binds to a cytosolic protein which is distinct from the cyclosporin A-binding protein, cyclophilin.
1989 • 137 citations
Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat.
1987 • 136 citations
Pharmacokinetics of FK 506: preclinical and clinical studies.
1990 • 124 citations
EFFECT OF A NEW IMMUNOSUPPRESSIVE AGENT, FK506, ON HUMAN LYMPHOCYTE RESPONSES IN VITRO
1989 • 104 citations
PROLONGATION OF SKIN ALLOGRAFT SURVIVAL IN RATS BY A NOVEL IMMUNOSUPPRESSIVE AGENT, FK 506
1988 • 101 citations
Physicochemical properties of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis.
1987 • 89 citations
Effects of a new immunosuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats.
1988 • 80 citations
Immunosuppressive effect of FK506 on collagen-induced arthritis in rats
1988 • 72 citations
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine.
1987 • 71 citations
Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506.
1989 • 69 citations
Effect of FK-506, a novel immunosuppressive drug on murine systemic lupus erythematosus
1989 • 69 citations
Renal transplantation in baboons under FK 506.
1990 • 64 citations
FK-506 enters the clinic
1990 • 64 citations
The side effects of FK 506 in humans.
1990 • 63 citations
Toxicology of FK-506 in the Lewis rat.
1987 • 63 citations
EFFECTS OF COMBINATION TREATMENT WITH FK506 AND CYCLOSPORINE ON SURVIVAL TIME AND VASCULAR CHANGES IN RENAL-ALLOGRAFT-RECIPIENT DOGS
1989 • 57 citations
Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids.
1987 • 56 citations
The oral dosage form of FK-506.
1987 • 51 citations
Biopharmaceutical aspects of FK-506.
1987 • 49 citations
IMMUNOSUPPRESSIVE ACTIVITY, LYMPHOCYTE SUBSET ANALYSIS, AND ACUTE TOXICITY OF FK-506 IN THE RAT. A COMPARATIVE AND COMBINATION STUDY WITH CYCLOSPORINE
1989 • 44 citations
FK-506 - A POTENTIAL BREAKTHROUGH IN IMMUNOSUPPRESSION
1987 • 40 citations
Kidney transplantation in the dog receiving FK-506.
1987 • 39 citations
The Influence of FK‐506 and Low‐Concentration Ciclosporin on Human Lymphocyte Activation Antigen Expression and Blastogenesis: a Flow Cytometric Analysis
1990 • 34 citations
Inhibition of murine B-lymphocyte proliferation by the novel immunosuppressive drug FK-506.
1989 • 33 citations
FK506
1988 • 32 citations
PROLONGATION OF CARDIAC XENOGRAFT SURVIVAL IN RATS TREATED WITH 15-DEOXYSPERGUALIN ALONE AND IN COMBINATION WITH FK506
1988 • 29 citations
Suppression of corneal graft rejection in rabbits by a new immunosuppressive agent, FK-506.
1989 • 29 citations
Effects of FK-506 on collagen arthritis in mice.
1989 • 25 citations
Observations about FK-506 in primates.
1987 • 23 citations
FK 506 inhibition of cyclosporine metabolism by human liver microsomes.
1991 • 21 citations
Heterotopic heart transplantation in the rat receiving FK-506.
1987 • 20 citations
Cyclosporin. Mode of Action and Clinical Application
1991 • 20 citations
Immunosuppressive activity of FK-506 in rats: flow cytometric analysis of lymphocyte populations in blood, spleen and thymus during treatment and following drug withdrawal
1990 • 19 citations
Histopathologic studies in renal transplant recipient dogs receiving treatment with FK-506.
1987 • 19 citations
A cost comparison of liver transplantation with FK 506 or CyA as the primary immunosuppressive agent.
1990 • 16 citations
Effect of FK-506 and cyclosporine on human lymphocyte responses in vitro.
1989 • 14 citations
Orthotopic liver transplantation in rats receiving FK506.
1989 • 13 citations
Effects of FK-506 on xenotransplantation of the heart and skin in a mouse-rat combination.
1987 • 12 citations
Toxicity of FK-506 in Human Fetal Pancreas
1989 • 11 citations
FK506—ITS INFLUENCE ON ANTI-CLASS 1 MHC ALLOANTIBODY RESPONSES TO BLOOD TRANSFUSIONS
1990 • 11 citations
Effect of a novel immunosuppressive agent, FK506, on mitogen-induced inositol phospholipid degradation in rat thymocytes.
1989 • 8 citations
Immunosuppressive activity, T-cell subset analysis, and acute toxicity of FK-506 in rats.
1989 • 7 citations
EFFECT OF A NOVEL IMMUNOSUPPRESSIVE AGENT, FK506, ON MITOGEN-INDUCED INOSITOL PHOSPHOLIPID DEGRADATION IN RAT THYMOCYTES
1989 • 6 citations
Effects of a novel immunosuppressive agent, FK-506, on islet allograft survival in the rat.
1989 • 5 citations
Pathological effects of cyclosporin A in clinical practice
1989 • 5 citations
Clinical transplantation : current practice and future prospects
1987 • 3 citations
Rejection, the Immune Response, and the Influence of Cyclosporin A
1987 • 1 citations